Contact
Pharma Data | Q&As & Interviews

Interview with Vaishak Belle, Chancellor’s Fellow and Reader at the School of Informatics, University of Edinburgh 

Edited by Tia Byer | 21 April 2023
Vaishak Belle, Chancellor’s Fellow and Reader at the University of Edinburgh, discusses his work on explainable AI and ethics.
https://www.youtube.com/watch?v=EQNbc-QNbTI

Get your weekly dose of industry news and announcements here, and keep up to date with the latest ‘Industry Spotlight’ posts. For other PharmaTec content, please visit the PharmaTec Content Portal.

Want to find out more about the innovations happening in pharma data? Join Oxford Global’s annual Pharma Data & Digital Medicine event today. This 2-day conference brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and exciting industry outlooks.

Speaker Biographies

Dr Vaishak Belle is a Chancellor’s Fellow and Reader at the School of Informatics, University of Edinburgh. He is an Alan Turing Institute Faculty Fellow, a Royal Society University Research Fellow, and a member of the RSE (Royal Society of Edinburgh) Young Academy of Scotland.

At the University of Edinburgh, he directs a research lab on artificial intelligence, specialising in the unification of logic and machine learning, with a recent emphasis on explainability and ethics. He has given research seminars at academic institutions such as MIT and Oxford, tutorials at AI conferences, and talks at venues such as Ars Electronica and the Samsung AI Forum.

He has co-authored over 70 scientific articles on AI, at venues such as IJCAI, UAI, AAAI, MLJ, AIJ, JAIR, AAMAS, and along with his co-authors, he has won the Microsoft best paper award at UAI, the Machine learning journal best student paper award at ECML-PKDD, and the Machine learning journal best student paper award at ILP. In 2014, he received a silver medal by the Kurt Goedel Society.

Belle has served on the senior program committee/area chair of major AI conferences, co-chaired the ML track at KR, among others, and as PI and CoI secured a grant income of close to 8 million pounds. Recently, he has consulted with major banks on explainable AI and its impact in financial institutions.

Related Resources

Funding Opportunity Announced for Generating Real-World Evidence in Regulatory Decision-Making

The U.S. Food and Drug Administration (FDA) is encouraging pharmaceutical developers to submit real-world evidence in support of regulatory applications.
Read More

The Evolution of Pharma Data Practices

Pharma data practices have evolved with the times. Today, approaches such as AI and machine learning afford the opportunity to enhance drug development and safety, culminating in AI-driven insights that promise better patient outcomes.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
20/03/24
The Design of Novel Drugs with Generative AI